Correlation Between Delek and Novolog Pharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Delek and Novolog Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Delek and Novolog Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Delek Group and Novolog Pharm Up 1966, you can compare the effects of market volatilities on Delek and Novolog Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Delek with a short position of Novolog Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Delek and Novolog Pharm.

Diversification Opportunities for Delek and Novolog Pharm

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Delek and Novolog is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Delek Group and Novolog Pharm Up 1966 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novolog Pharm Up and Delek is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Delek Group are associated (or correlated) with Novolog Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novolog Pharm Up has no effect on the direction of Delek i.e., Delek and Novolog Pharm go up and down completely randomly.

Pair Corralation between Delek and Novolog Pharm

Assuming the 90 days trading horizon Delek Group is expected to generate 0.97 times more return on investment than Novolog Pharm. However, Delek Group is 1.03 times less risky than Novolog Pharm. It trades about 0.05 of its potential returns per unit of risk. Novolog Pharm Up 1966 is currently generating about -0.02 per unit of risk. If you would invest  3,196,640  in Delek Group on September 13, 2024 and sell it today you would earn a total of  1,497,360  from holding Delek Group or generate 46.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Delek Group  vs.  Novolog Pharm Up 1966

 Performance 
       Timeline  
Delek Group 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Delek Group are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Delek unveiled solid returns over the last few months and may actually be approaching a breakup point.
Novolog Pharm Up 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Novolog Pharm Up 1966 are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Novolog Pharm sustained solid returns over the last few months and may actually be approaching a breakup point.

Delek and Novolog Pharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Delek and Novolog Pharm

The main advantage of trading using opposite Delek and Novolog Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Delek position performs unexpectedly, Novolog Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novolog Pharm will offset losses from the drop in Novolog Pharm's long position.
The idea behind Delek Group and Novolog Pharm Up 1966 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments